Related Experiment Video
Updated: Apr 30, 2026

10:33
Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts
Published on: April 29, 2014
10.3K
From Normal Mucosa to Colorectal Cancer in Lynch Syndrome: Single-Cell Dissection of Cellular Heterogeneity and
Shangxiang Chen1, Jishen Feng1, Zhengkai Fang1
1Department of General Surgery, The 1st Affiliated Hospital, Jiangxi Medical College, Nanchang University, 330006 Nanchang, Jiangxi, China.
Frontiers in Bioscience (Landmark Edition)
|April 29, 2026
Summary
This study maps colorectal cancer (CRC) development in Lynch syndrome (LS) using single-cell sequencing. It reveals key cellular changes and identifies DMBT1 loss and immune shifts as potential therapeutic targets for LS-CRC.
Area of Science:
- Genomics and Molecular Biology
- Cancer Research
- Immunology
Background:
- Lynch syndrome (LS) significantly increases colorectal cancer (CRC) risk.
- Understanding the cellular dynamics of LS-CRC development is crucial for targeted therapies.
- A comprehensive single-cell atlas of LS-CRC progression is lacking.
Purpose of the Study:
- To create a single-cell atlas of colorectal cancer (CRC) development in Lynch syndrome (LS).
- To identify cellular reprogramming events during LS-CRC progression.
- To delineate intercellular communication networks in the LS-CRC microenvironment.
Main Methods:
- Single-cell RNA sequencing (scRNA-seq) on matched normal, adenoma, and carcinoma tissues from LS patients.
- Bioinformatic analyses including UMAP clustering, differential gene expression, and Gene Set Variation Analysis (GSVA).
- Functional validation using patient-derived organoids and transwell assays; Cell Chat for communication network inference.
Main Results:
- Identified twelve cell clusters with significant compositional shifts during CRC progression (increased lymphocytes/macrophages, decreased epithelial cells).
- Revealed a differentiation trajectory from BEST4+ to CEMIP+/EGFR+ epithelial cells.
- Demonstrated DMBT1 downregulation activates WNT/β-catenin, promoting growth and migration; identified an immunosuppressive microenvironment with expanded regulatory T cells and specific macrophage populations.
Conclusions:
- This study provides a valuable single-cell resource for LS-associated CRC.
- Highlights DMBT1 loss, epithelial remodeling, and immune dysregulation as key features of LS-CRC.
- Suggests these factors as potential therapeutic targets for LS-CRC.

